Review of the EU 2020 PRIME Priority Medicines Program
New medicine for rare lung disease! Roche Esbriet (pyridone) is reviewed by the FDA as a priority
The European Medicines Agency (EMA) has begun a review of GBT's sickle cell therapy Oxbryta
Review of the development of Chinese medicine in 2020
200 million antimicrobial injections! Shi Shi medicine won the first review
The first 10 months by the CDE priority review of 40 enterprises involving Hengrui, Junshi, stone medicine....
New migraine medicine! Lingbei CGRP targeted antibody Vyepti entered the EU review: the first day of effective, 4 times a year intravenous dosing!